Evolution of the Average Target: GE HealthCare Technologies Inc.

Evolution of the Target Price: GE HealthCare Technologies Inc.

Changes in Analyst Recommendations: GE HealthCare Technologies Inc.

e22bdd79675945c5275bf6f08.OHN04_mz2WKd2TYkUT50t68cjJ_harObz8euAbtmAz4.fCEu2pTYijbavQJCMEgS59pPuMiDGNfDnaLCZOwfVFxIP0SrveKoN9q8RQ~8fb28e989cef51fb4b420def879b1038
08:01am HSBC Adjusts Price Target on GE Healthcare Technologies to $100 From $87, Maintains Buy Rating MT
Nov. 24 Sector Update: Health Care Stocks Advance Late Afternoon MT
Nov. 24 Sector Update: Health Care Stocks Advance in Afternoon Trading MT
Oct. 30 BTIG Adjusts GE Healthcare Technologies Price Target to $87 From $89 MT
Oct. 30 Goldman Sachs Adjusts Price Target on GE Healthcare Technologies to $86 From $84 MT
Oct. 30 Rothschild & Co Redburn Adjusts Price Target on GE Healthcare Technologies to $108 From $106 MT
Oct. 30 HSBC Adjusts Price Target on GE Healthcare Technologies to $87 From $86 MT
Oct. 29 Wells Fargo Lowers Adjusts GE Healthcare Technologies Price Target to $87 From $89 MT
Oct. 29 Morgan Stanley Adjusts GE Healthcare Technologies Price Target to $80 From $74, Maintains Equal Weight Rating MT
Oct. 29 Evercore ISI Adjusts GE Healthcare Technologies Price Target to $92 From $88, Keeps Outperform Rating MT
Oct. 13 BTIG Adjusts Price Target on GE Healthcare Technologies to $89 From $87, Maintains Buy Rating MT
Oct. 13 Barclays Initiates GE Healthcare Technologies With Equalweight Rating, $86 Price Target MT
Oct. 07 Citigroup Downgrades GE Healthcare Technologies to Neutral From Buy, Adjusts PT to $83 From $93 MT
Oct. 01 Goldman Sachs Adjusts Price Target on GE Healthcare Technologies to $84 From $83, Maintains Buy Rating MT
Jul. 31 HSBC Adjusts GE Healthcare Technologies Price Target to $86 From $97, Maintains Buy Rating MT
Jul. 31 BNP Paribas Exane Adjusts GE Healthcare Technologies Price Target to $92 From $83, Maintains Outperform Rating MT
Jul. 31 Goldman Sachs Adjusts GE Healthcare Technologies Price Target to $83 From $85, Maintains Buy Rating MT
Jul. 30 Citigroup Raises GE Healthcare Technologies Price Target to $93 From $89, Buy Rating Maintained MT
Jul. 30 Morgan Stanley Adjusts GE Healthcare Technologies Price Target to $74 From $78, Maintains Equal Weight Rating MT
Jul. 30 Evercore ISI Adjusts GE Healthcare Technologies Price Target to $88 From $85, Keeps Outperform Rating MT
Jul. 09 Citigroup Raises GE Healthcare Technologies Price Target to $89 From $86, Buy Rating Maintained MT
Jun. 02 DBS Bank Adjusts Price Target on GE Healthcare Technologies to $90 From $80, Maintains Buy Rating MT
Jun. 02 Goldman Sachs Adjusts Price Target on GE Healthcare Technologies to $85 From $82, Maintains Buy Rating MT
May. 08 HSBC Adjusts GE Healthcare Technologies Price Target to $98 From $100, Maintains Buy Rating MT
May. 08 Argus Adjusts Price Target on GE Healthcare Technologies to $90 From $110, Maintains Buy Rating MT
More recommendations

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+3.1%
+9.27%
+3.65%
+13%
+29.7%
+31.22%
+10.69%
+16.43%
+14.39%
+38.37%
Average +16.98%
Weighted average by Cap. +14.33%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
85.46USD
Average target price
88.76USD
Spread / Average Target
+3.86%
High Price Target
108.00USD
Spread / Highest target
+26.37%
Low Price Target
73.00USD
Spread / Lowest Target
-14.58%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BTIG
Goldman Sachs
Rothschild & Co Redburn
HSBC
Wells Fargo Securities
Morgan Stanley
Evercore ISI
Barclays
Citigroup
BNP Paribas Exane
DBS Bank
Argus
UBS
Redburn Atlantic
Stifel Nicolaus
Oppenheimer
Jefferies & Co.
JPMorgan Chase
Piper Sandler
Mizuho Securities
BofA Securities
Redburn
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
85.46USD
Average target price
88.76USD
Spread / Average Target
+3.86%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. GEHC Stock
  4. Consensus GE HealthCare Technologies Inc.